SEC Tracker
Get the app

Amarillo Biosciences AIMD

Amarillo Biosciences FY 2020: revenue $17K

Form
10-K
Filed
Period
Importance
Notable
Document
10-K
Exhibit 99.1
906 certification

Key figures from this report

These are the numbers Amarillo Biosciences reported for the year ended Dec 31, 2020, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$17KNo year-earlier figure tagged10-K income statement, on EDGAR
  2. Net income−$1.5MNo year-earlier figure tagged10-K income statement, on EDGAR
  3. Cash and cash equivalents$22KNo year-earlier figure tagged10-K balance sheet, on EDGAR
  4. Cash from operations−$500KNo year-earlier figure tagged10-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Amarillo Biosciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3577 and related industry codes: the same peer list as the financial tables.

  1. Socket Mobile SCKT public float $7M, Jun 25, 2025
  2. Interlink Electronics LINK public float $8M, Jun 30, 2025
  3. Wetouch Technology WETH public float $11M, Jun 30, 2025
  4. Foxx Development Holdings FOXX public float $13M, Dec 31, 2025
  5. Tianci International CIIT public float $16M, Jan 31, 2026

Data on this page was fetched . The filing on SEC.gov is the record.